Sanctuary Advisors LLC purchased a new position in Stericycle, Inc. (NASDAQ:SRCL - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 15,700 shares of the business services provider's stock, valued at approximately $913,000.
Several other large investors also recently added to or reduced their stakes in SRCL. Pentwater Capital Management LP bought a new stake in Stericycle during the second quarter valued at approximately $83,010,000. Magnetar Financial LLC bought a new position in shares of Stericycle in the second quarter worth approximately $81,596,000. Millennium Management LLC boosted its position in shares of Stericycle by 1,057.6% in the second quarter. Millennium Management LLC now owns 1,315,274 shares of the business services provider's stock worth $76,457,000 after purchasing an additional 1,201,653 shares during the period. Alpine Associates Management Inc. bought a new position in shares of Stericycle in the second quarter worth approximately $62,298,000. Finally, Capital Research Global Investors boosted its position in shares of Stericycle by 11.4% in the first quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider's stock worth $351,732,000 after purchasing an additional 679,974 shares during the period. 98.82% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Separately, StockNews.com began coverage on shares of Stericycle in a research report on Friday. They issued a "hold" rating for the company. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $74.00.
Check Out Our Latest Stock Analysis on SRCL
Stericycle Price Performance
Shares of SRCL stock traded down $0.11 during mid-day trading on Friday, hitting $60.81. The company had a trading volume of 1,609,036 shares, compared to its average volume of 1,617,476. Stericycle, Inc. has a 52-week low of $37.78 and a 52-week high of $61.77. The stock's 50 day moving average price is $60.11 and its 200-day moving average price is $55.75. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.13 and a quick ratio of 1.13. The company has a market capitalization of $5.65 billion, a P/E ratio of 160.03, a P/E/G ratio of 3.33 and a beta of 1.11.
Stericycle (NASDAQ:SRCL - Get Free Report) last released its earnings results on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, topping the consensus estimate of $0.57 by $0.04. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. The firm had revenue of $661.60 million for the quarter, compared to the consensus estimate of $672.07 million. Equities research analysts forecast that Stericycle, Inc. will post 2.29 earnings per share for the current year.
Stericycle Company Profile
(
Free Report)
Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.
Featured Stories
Before you consider Stericycle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stericycle wasn't on the list.
While Stericycle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.